We describe here the successful establishment of a reverse genetics system for rotavirus (RV), a member of the Reoviridae family whose genome consists of 10 -12 segmented dsRNA. The system is based on the recombinant vaccinia virus T7 RNA polymerase-driven procedure for supplying artificial viral mRNA in the cytoplasm. With the aid of helper virus (human RV strain KU) infection, intracellularly transcribed full-length VP4 mRNA of simian RV strain SA11 resulted in the rescue of the KU-based transfectant virus carrying the SA11 VP4 RNA segment derived from cDNA. In addition to the rescued transfectant virus with the authentic SA11 VP4 gene, three more infectious RV transfectants, into which silent mutation(s) were introduced to destroy both or one of the two restriction enzyme sites as gene markers in the SA11 VP4 genome, were also rescued with this method. The ability to artificially manipulate the RV genome will greatly increase the understanding of the replication and the pathogenicity of RV and will provide a tool for the design of attenuated vaccine vectors.
We describe here the successful establishment of a reverse genetics system for rotavirus (RV), a member of the Reoviridae family whose genome consists of 10 -12 segmented dsRNA. The system is based on the recombinant vaccinia virus T7 RNA polymerase-driven procedure for supplying artificial viral mRNA in the cytoplasm. With the aid of helper virus (human RV strain KU) infection, intracellularly transcribed full-length VP4 mRNA of simian RV strain SA11 resulted in the rescue of the KU-based transfectant virus carrying the SA11 VP4 RNA segment derived from cDNA. In addition to the rescued transfectant virus with the authentic SA11 VP4 gene, three more infectious RV transfectants, into which silent mutation(s) were introduced to destroy both or one of the two restriction enzyme sites as gene markers in the SA11 VP4 genome, were also rescued with this method. The ability to artificially manipulate the RV genome will greatly increase the understanding of the replication and the pathogenicity of RV and will provide a tool for the design of attenuated vaccine vectors.
rescue of transfectant virus ͉ viral selection system ͉ Reoviridae R otavirus (RV) is the leading etiological agent of severe gastroenteritis in infants and young children worldwide and is estimated to cause 440,000 deaths and 140 million episodes of diarrhea each year (1, 2) . As a member of the Reoviridae family, RV is a dsRNA virus that possesses an 11-segment genome (3) . Most positive-and negative-stranded RNA viruses (reviewed in refs. [4] [5] [6] [7] [8] can be altered through site-specific mutagenesis by using cloned cDNA. Such reverse genetics systems allow artificial manipulation of viral genomes at the cDNA level by site-directed mutagenesis, deletion͞insertion, and rearrangement and have led to the accumulation of significant new knowledge relating to the replication, biological characteristics, and pathogeneses of these viral genera and families (5, 9) . For dsRNA viruses, which comprise three families, the Reoviridae, Birnaviridae, and Cystoviridae, such achievements have so far been restricted to the low-numbered segmented dsRNA viruses: two segmented birnaviruses (10, 11) and three segmented 6 bacteriophage of the Cystoviridae (12) . The Reoviridae viruses that possess 10-12 segmented genomes have been proven to be very refractory to this approach, except for the reoviruses. Roner and Joklik (13-15) developed a unique but complicated reovirus reverse genetics system involving temperature-sensitive mutants and transformed cells that stably express a particular viral protein encoded by the gene segment to be manipulated. However, there have been no reports on the performance of this method in other laboratories or its application to other Reoviridae members so far.
Since the first development of an RV template-dependent in vitro replication system in 1994 (16) in which the RV open core can direct the synthesis of genomic dsRNA from viral mRNA in a cell-free system, no infectious RV transfectants have been rescued at all as far as we know, despite intensive attempts at the establishment of RV reverse genetics systems around the world in the last decade. This long lack of progress has led to pessimism regarding the possibility of the development of a reverse genetics system for RV and has made it difficult to determine which methodology is feasible for RV reverse genetics. In the RV replication cycle, mRNAs transcribed from the respective genome segments by viral RNAdependent RNA polymerase (RdRp) are also being used as templates for the synthesis of minus-strand RNAs, resulting in the formation of genome dsRNAs (16, 17) . Thus, theoretically, a cDNA-derived artificial plus-strand RNA corresponding to the natural viral mRNA introduced into cells should be recognized and replicated to yield dsRNA by means of RdRp supplied by the helper virus, and packaged into the virus particles to give rise to an infectious virus containing a gene segment derived from the cDNA.
Here we show that an infectious RV containing a previously undescribed gene segment derived from cDNA was generated with a reverse genetics system. We also describe the rescue of previously undescribed RVs that have site-specific mutations in their VP4 gene genomes derived from an artificially manipulated cDNA genome. Manipulation of the RV genome at the DNA level will allow detailed analysis of its replication and pathogenicity and will provide a tool for the design of attenuated vaccine vectors. This system will also be applicable to other Reoviridae viruses.
Results
Structure of SA11 VP4 Gene cDNA. To generate an infectious RV transfectant that contains the previously undescribed cDNAderived gene segment, we used the helper virus-driven reverse genetics procedure, which was developed originally for influenza viruses by Palese and colleagues (18) (19) (20) , with some modifications. This procedure requires a strong selection system for the transfectant virus containing the cDNA-derived gene because the majority of virus in the culture fluid is helper virus. Because we obtained some neutralizing monoclonal antibodies (NMAbs) against VP4 spike protein that specifically neutralize human RV strains exhibiting P [8] -type specificity, such as strain KU, without affecting the replication of viruses with VP4 of the non-P [8] type, such as strain SA11 (P [2] ), we attempted to rescue a transfectant virus that contains the SA11 cDNA-derived VP4 gene segment in the background of helper KU viruses by passages in the presence of such N-MAbs. This strategy is also conceivably advantageous, because the growth of RV with the SA11 VP4 gene was found to be much better than that of the original RV in reassortment experiments (21) .
First, we cloned the full-length VP4 gene of SA11 flanked by the T7 RNA polymerase promoter and the hepatitis delta virus (HDV) ribozyme followed by the T7 RNA polymerase terminator ( Fig. 1  A and B) . Thus, transcription of the resulting vector, pT7͞ VP4(SA11), allows production of a 2,362-nt-long positive-strand RNA with the correct 5Ј and 3Ј ends corresponding to the ends of authentic SA11 VP4 mRNA.
Transfection of cDNA Encoding the Full-Length SA11 VP4 Gene and
Rescue of Viruses Containing the cDNA-Derived VP4 Genome. The transfection experiment on the constructed transcription plasmid, pT7͞VP4(SA11), was carried out with COS-7 cells that had been infected 1 h earlier with the recombinant vaccinia virus to supply the T7 RNA polymerase. The recombinant vaccinia virus strain, rDIs-T7pol, was selected for its low pathogenicity toward COS-7 and other mammalian cell lines (22) . One day after transfection, the transfected cells were infected with KU as the helper virus and then cultured for a further 24 h until harvest. The culture fluid collected was subjected to passages in MA104 cells in the presence of two N-MAbs, ST-1F2 and YO-2C2, that specifically neutralize the KU helper virus. Although significant cytopathic effect could not be observed in the first passage, MA104 cells in the second passage showed cytopathic effect, suggesting the generation of transfectant viruses with the rescued VP4 gene derived from cDNA. The rescued virus was biologically cloned by three successive plaqueto-plaque purifications in CV-1 cells to isolate clones and to exclude the possibility of sequestrated irrelevant dsRNAs by core particles as described for avian reovirus (23) and bluetongue virus (24) . After amplification in MA104 cells, the virus particles of transfectant clones were purified by isopycnic CsCl gradient centrifugation and subsequent fractionation, followed by a single major band formation (data not shown). The virus particles in the band were identified as triple-layered particles (TLPs) by their density and viral protein composition (data not shown) and then used for subsequent experiments.
RNA Analysis of Rescued Viruses. Virion dsRNAs were extracted and then analyzed by PAGE. Fig. 2A shows the profiles of the dsRNAs from the KU used for the helper virus (lanes 1 and 7) and SA11 virus used for the VP4 gene cloning (lane 6). The VP4 gene dsRNA in lane 2 migrated to the same position as the corresponding dsRNA of SA11 (lane 6), the mobility being slower than that of the VP4 gene segment of the KU helper virus (lanes 1 and 7). Furthermore, sequence analysis of the RT-PCR fragment of the VP4 gene of the rescued virus showed it was derived from SA11 (data not shown). The VP4 gene of KU and SA11 is 2,359-nt and 2,362-nt long, respectively, and the identity at the nucleotide level between them is 71.0% (data not shown). Thus, an infectious RV transfectant containing the cDNA-derived VP4 gene segment, named KU͞͞rVP4(SA11) virus, could be recovered as a result of cDNA transfection, followed by infection with helper virus.
Serological Characterization of Rescued Viruses. The VP4 protein produced by rescued viruses was analyzed by antigen capture ELISA with anti-VP4 N-MAbs, ST-1F2 and KU-6B11. As shown in Fig. 2B , KU͞͞rVP4(SA11) showed no reactivity with ST-1F2 that selectively reacts with P [8] type, such as KU helper virus (G1P [8] ), but reacted with KU-6B11 that is found to commonly react with both P [8] and P [2] types, including SA11 virus (G3P [2] ), whereas the rescued virus reacted with anti-VP7 N-MAb KU-4 specific for G1 type but not with YO-1E2 for G3 type. These serological results were consistent with the results of the RNA analysis, confirming that rescued KU͞͞rVP4(SA11) is the KUbased transfectant virus carrying the SA11 VP4 proteins expressed from the cDNA-derived VP4 genome and that the rescued viruses are quite stable in repeated cell cultures.
Introduction of Site-Specific Mutations into the Genome of Infectious
RV. We then introduced four silent mutations as gene markers into the coding region of the VP4 gene in plasmid pT7͞VP4(SA11) by PCR-based site-directed mutagenesis. The four mutations in the cDNA comprised T-to-A at position 1,365 and A-to-C at position 1,368 as well as A-to-G at position 1,569 and G-to-A at position 1,572, destroying the unique PstI site at position 1,364 and the HaeII site at position 1,569, respectively. The previously undescribed plasmids, pT7͞VP4(SA11)-⌬PstI, pT7͞VP4(SA11)-⌬HaeII, and pT7͞VP4(SA11)-⌬PstI,⌬HaeII, contained the destruction mutation(s) at the PstI site, the HaeII site, and at both, respectively. Transfection of each mutagenized plasmid into COS-7 cells, which had previously been infected with the recombinant vaccinia virus, followed by superinfection with the helper virus, resulted in the rescue and isolation of transfectant virus clones named KU͞͞ rVP4(SA11)-⌬PstI, KU͞͞rVP4(SA11)-⌬HaeII, and KU͞͞ rVP4(SA11)-⌬PstI,⌬HaeII, respectively, that grew in the presence of the helper virus-specific N-MAbs. After the third plaque-toplaque purification of each virus clones, individual TLPs of the previously undescribed viruses were purified by CsCl gradient density centrifugation and then used for subsequent characterization experiments. The virion dsRNAs were extracted and subjected to PAGE and RT-PCR of the entire VP4 sequences, and the VP4 proteins of the virions were characterized by ELISA analysis. On PAGE analysis, the mobility of the fourth segment of the recovered viruses was found to be the same as that of strain SA11 (Fig. 2 A,  lanes 3-5) . On RT-PCR-restriction enzyme digestion analysis, the 2,386-bp product of the authentic VP4 gene from KU͞͞ rVP4(SA11) virus, which includes extra 24 bp encoded by 5Ј terminus of primer 2, was digested with PstI or HaeII into 1,392 and 994 bp, or 1,597 and 789 bp, ones, respectively (Fig. 3A) . In contrast, the corresponding DNA fragments from previously undescribed transfectant viruses could not be cut with PstI and͞or HaeII, as planned in the plasmid constructions (Fig. 3A) . Furthermore, direct sequence analysis of the PCR products also revealed the correct presence of these silent mutations within the genomes of the rescued viruses (Fig. 3B) . In antigen capture ELISA analysis, the rescued viruses showed no reactivity with anti-VP4 N-MAb ST-1F2 (P[8]-specific) but reacted with KU-6B11 (cross-reactive) (Fig. 2B) . Thus, successful rescue of infectious RVs containing site-specific mutations in their genomes was achieved via transfection of cloned cDNA, followed by helper virus infection in a recombinant vaccinia virus T7 RNA polymerase-driven system.
Discussion
The approach described here represents a successful reverse genetics system for RVs and involves infection with a recombinant vaccinia virus expressing T7 RNA polymerase and superinfection with a helper virus. Concerning the viruses in the family Reoviridae, Roner and Joklik (13) (14) (15) have reported reverse genetics to generate reovirus transfectants, but the system requires very complicated techniques and very tedious preparation of temperature-sensitive mutants and transformed cells that stably express a particular viral protein encoded by the gene segment to be manipulated. There have been no reports on its application in other laboratories or to other Reoviridae viruses. In contrast, we demonstrated that the reverse genetics system involving the traditional T7 RNA polymerase expression system (25) developed by Palese and colleagues (18) (19) (20) could be applied to RVs with some modifications. The recombinant vaccinia virus T7 RNA polymerase-driven system allows extremely high expression of artificial viral mRNAs mimicking the natural RV mRNAs in the cytoplasm, which is favorable for the development of reverse genetics for RVs whose entire replication cycle is completed in the cytoplasm.
RV mRNAs are unique in that they possess a 5Ј cap structure but lack 3Ј poly(A) tails (26, 27) , and several studies have revealed the importance of these structures for efficient genome replication and translation (28) (29) (30) . In this study, each of the authentic 5Ј and 3Ј end structures were planned to be obtained with vaccinia virus-encoded capping enzyme and the HDV ribozyme sequences inserted in the transcription plasmids (Fig. 1) , respectively. Intracellularly transcribed viral mRNA derived from cDNA in the recombinant vaccinia virus T7 RNA polymerase-driven system was used, with the aid of helper virus infection, to rescue an infectious RV that contains the previously undescribed cDNA-derived gene segment. For the selection of such transfectant viruses, we chose a system that requires the presence of a simian RV strain SA11-like VP4 gene in the rescued viruses. The growth of viruses containing this gene was not restricted in the presence of N-MAbs that selectively neutralize the helper virus (human RV strain KU)-derived VP4 gene, but rather the virus with the SA11-VP4 gene could multiply much better than the helper virus. In the experiments presented, we first recovered KU͞͞rVP4(SA11) virus, which contains the authentic SA11-origin VP4 gene derived from plasmid pT7͞VP4(SA11) (Fig.  1 A) . KU͞͞rVP4(SA11) virus exhibits the expected RNA pattern (Fig. 2 A) , VP4 gene sequence (data not shown), and reactivity with anti-VP4 and VP7 N-MAbs (Fig. 2B ) and grew to reach almost the same titers in MA104 cells to those of the SA11 virus used for the VP4 gene cloning (data not shown). The different growth characteristics of KU͞͞rVP4(SA11) virus from those of the parental KU were expected from the previous finding that VP4 protein often largely confers RV infectivity (17, 31, 32) .
We also rescued three transfectant viruses that have silent mutations to destroy the original restriction enzyme site(s) as gene markers in their VP4 genomes, derived from plasmids pT7͞VP4(SA11)-⌬PstI, pT7͞VP4(SA11)-⌬HaeII, and pT7͞ VP4(SA11)-⌬PstI,⌬HaeII (Fig. 1) . We verified the presence of these mutations in the rescued mutant viruses (KU͞͞ rVP4(SA11)-⌬PstI, KU͞͞rVP4(SA11)-⌬HaeII, and KU͞͞ rVP4(SA11)-⌬PstI,⌬HaeII) by RT-PCR-restriction enzyme digestion analysis and sequence analysis of the virion dsRNAs (Fig.  3) . These mutations did not result in any amino acid change in VP4 protein and, thus, were not expected to change the biological properties of KU͞͞rVP4(SA11) virus with the authentic SA11-derived VP4 gene. In fact, all of the rescued mutant viruses showed no reactivity to the P[8]-specific anti-VP4 N-MAb ST-1F2 (Fig. 2B ) and growth characteristics (data not shown) indistinguishable from those of KU͞͞rVP4(SA11) virus. Thus, we confirmed the utility of the reverse genetics system developed here for RVs. However, there is a problem to be considered. In a typical experiment, at least one series of three transfections on 60-mm dishes were required to isolate each transfectant virus under the present conditions (data not shown). The cause for the low efficiency of the transfectant virus recovery might be the very strict control of packaging of the exact number of genome segments per virion, and͞or the hard accessibility of artificial RV mRNAs to viroplasm as reported by Silvestri et al. (33) ; however, the efficiency of the system must be improved.
The introduction of mutations that change the biological characteristics of RVs would help to define the precise functions of all of the viral proteins, including those of nonstructural proteins. Concerning the VP4 protein, for example, researchers could soon be able to perform direct assessment of the relationship between trypsin cleavability at the conserved arginines and the virulence of RVs by using the reverse genetics system. The untranslated regions of the genome could also be studied by means of mutagenesis, leading to a better understanding of the regulatory signals present in viral RNAs. Furthermore, this reverse genetics system provides the opportunity to identify attenuation markers within the RV genome segments and, thus, will facilitate the development of attenuated recombinant viruses that could be used as vaccine or vaccine vector candidates. Clearly, there are limitations to our helper virus-dependent reverse genetics because of the requirement of a strong selection system, such as the N-MAbs selection system used in this study. For gene segments that do not encode viral surface proteins, other gene-specific selection procedures, such as host-range restriction and temperature sensitivity, will be required. Nevertheless, the current approach has immediate promise in several areas, particularly with respect to the study of the functions of viral proteins and the signals involved in the transcription, replication, and packaging of RV genome dsRNAs, which will also lead to a further goal: establishment of a helper virus-free system to generate infectious RVs entirely from cloned cDNAs.
Materials and Methods
Viruses. Human RV strain KU (G1P [8] ) (34) and simian RV strain SA11 (SA11-L2) (G3P [2] ) (35) were pretreated with trypsin (type IX, from porcine pancreas and crystallized) (10 g͞ml; Sigma) and then propagated in MA104 cells in the presence of trypsin (1 g͞ml). Recombinant vaccinia virus rDIs-T7pol (22), kindly provided by Y. Matsuura (Research Institute for Microbial Diseases, Osaka University, Osaka), which was designed to express the T7 RNA polymerase, was grown in chicken embryo fibroblasts.
Cell Culture and Infection. Epithelial monkey kidney cell lines COS-7, MA104, and CV-1 were cultured in Eagle's minimum essential medium supplemented with 5% FCS (complete medium).
Monolayers of the cells were inoculated with RV pretreated with trypsin (10 g͞ml) for 30 min at 37°C. After adsorption for 1 h at 37°C, the infected cells were washed with minimum essential medium without FCS (incomplete medium) and then cultured in incomplete medium containing trypsin (1 g͞ml) until harvest. The cultures were subjected to three cycles of freezing and thawing and then centrifuged at low speed to remove cell debris. The supernatants were used for RV infection experiments.
Construction of Authentic VP4 Gene cDNA of SA11. dsRNA of SA11 was extracted from the culture fluid with a disruption solution (1% SDS͞0.1% 2-mercaptoethanol͞60 mM EDTA) and then with phenol-chloroform. cDNA of the SA11 VP4 gene was synthesized from virion dsRNA with avian myeloblastosis virus reverse transcriptase (Seikagaku Kogyo, Tokyo) and primer 1 (Table 1) as described in ref. 36 . cDNA encoding the full-length VP4 gene (2.4 kb) was amplified by PCR with KOD-Plus (TOYOBO, Osaka) and primers 1 and 2. Primer 2 contains the T7 promoter sequence and a 23-base sequence corresponding to the 5Ј terminus of the SA11 VP4 gene. After digestion with HindIII, amplified cDNA was ligated into the HindIII and SmaI sites of T7 expression vector pX8dT (37) (kindly provided by Y. Matsuura, which was originally developed by K. K. Conzelmann (Ludwig-Maximilians-University, Munich). The generated plasmid, pT7͞VP4(SA11), contains the authentic full-length VP4 gene cDNA of SA11, flanked by the T7 RNA polymerase promoter and the HDV ribozyme, followed by the T7 RNA polymerase terminator.
Introduction of Genetic Markers into the RV Genome. Manipulation of the VP4 gene was carried out in plasmid pT7͞VP4(SA11). Destruction of the unique PstI and HaeII sites (positions in the VP4 gene of SA11: 1,364 and 1,569, respectively) by artificial introduction of silent mutations was achieved with a QuikChange XL site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. Briefly, pT7͞VP4(SA11) was amplified with mutated nucleotide primers 3 and 4 and primers 5 and 6 to change the SA11 PstI and HaeII site nucleotide sequences, respectively. After digestion with DpnI to eliminate the pT7͞VP4(SA11) used as a template, the PCR products were used to transform Escherichia coli-competent cells. The generated plasmids, pT7͞VP4(SA11)-⌬PstI and pT7͞VP4(SA11)-⌬HaeII, have silent mutations at the PstI and HaeII site, respectively. Furthermore, plasmid pT7͞ VP4(SA11)-⌬PstI,⌬HaeII, which has mutations at both the PstI and HaeII sites, was also prepared by using template pT7͞ VP4(SA11)-⌬HaeII and primers 3 and 4 by a similar method to that described above. Newly generated plasmids were all identified to be appropriate clones by confirming their sequences.
Reverse Genetics System. COS-7 cells were seeded at a concentration of 2.5 ϫ 10 5 cells͞ml in 60-mm dishes. After overnight culture, 5 g of pT7͞VP4(SA11), pT7͞VP4(SA11)-⌬PstI, pT7͞VP4(SA11)-⌬HaeII, or pT7͞VP4(SA11)-⌬PstI,⌬HaeII plasmid DNA was transfected into COS-7 cells, which had been infected 1 h before with rDIs-T7pol at a multiplicity of infection (MOI) of 3, with the use of TransIT LT-1 (Mirus, Madison, WI) according to the manufacturer's instructions. Twenty hours after transfection, the transfected cells were washed twice with incomplete medium and then infected with KU as the helper virus at a MOI of 3. Twentyfour hours after the helper virus infection, the cultures were harvested, and transfectant viruses with the VP4 gene segment derived from SA11 cDNA were selected as described below. For selection of transfectant viruses containing the cDNAderived VP4 gene segment, the harvested viruses were activated with trypsin, followed by inoculation onto MA104 cell monolayers cultured in 60-mm dishes. After 1 h adsorption, the infected cells were washed with incomplete medium twice and then subjected to 7 days' culture in incomplete medium with trypsin (1 g͞ml) and anti-VP4 N-MAbs ST-1F2 (38) and YO-2C2 (39) that selectively neutralize KU helper virus of the P [8] type. After single mock passage, the RV-induced cytopathic effect was observed, and then the cultures were harvested and subjected to a further passage to amplify the transfectant viruses. The rescued transfectant viruses were then triply plaque-to-plaque purified in CV-1 cells by picking up every five plaques as described in ref. 38 .
Purification of RV Particles of the Rescued Transfectants Containing
the cDNA-Derived VP4 Genome Segment. The plaque-purified transfectant viruses were propagated in MA104 cells. After the virus particles were pelleted from the supernatants by centrifugation at 100,000 ϫ g for 3 h and resuspended in PBS containing 0.5 mM MgCl 2 and 1 mM CaCl 2 (PBS), it was followed by isopycnic CsCl (0.475 g͞ml) gradient density centrifugation at 100,000 ϫ g for 18 h and subsequent fractionation as described in ref. 39 . The virus band corresponding to the TLPs was collected and pelleted by centrifugation at 100,000 ϫ g for 3 h and then dissolved in PBS.
Identification of the cDNA-Derived VP4 Gene in the Rescued Viruses.
The genomic dsRNAs of rescued viruses were extracted from the purified TLPs. The precipitated virion dsRNAs were used for (i) PAGE analysis, (ii) RT-PCR restriction enzyme digestion analysis, and (iii) sequence analysis. For PAGE analysis, the dsRNAs were electrophoresed in a 10% acrylamide gel (2-mm thick) for 16 h at 20 mA at room temperature and then visualized by silver staining (35) . For RT-PCR restriction enzyme digestion analysis, dsRNAs were converted to cDNAs by incubation with SuperScript II RT (Invitrogen) with primer 1, and full-length VP4 genes were then amplified with primers 1 and 2. PCR products were digested with PstI or HaeII, and the resulting fragments were separated by 1.25% agarose gel electrophoresis in Tris-acetate-EDTA buffer. Gels were stained with ethidium bromide. For sequence analysis, the PCR products were sequenced directly with an ABI PRISM 310 automated sequencer (PerkinElmer) by using a DYEnamic ET terminator cycle sequencing kit (Amersham Pharmacia Biosciences). [8] ), whereas KU-6B11 commonly reacts with both P [8] and P [2] types, including SA11 virus (G3P [2] ). The anti-VP7 N-MAbs, KU-4 and YO-1E2, selectively react with G1 and G3 type, respectively.
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